Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users. (2nd January 2018)

• Record Type: Journal Article
• Authors: Loflin, Mallory; Babson, Kimberly; Browne, Kendall; Bonn-Miller, Marcel
• Is Part Of: American journal of drug and alcohol abuse. Volume 44:Number 1(2018:Jan.)
• Page Start: 19
• Page End: 23
• Publication Date: 2018-01-02
• Subjects: CUDIT-R -- veterans -- medicinal cannabis -- cannabis use disorders; Drug abuse -- Treatment -- Periodicals; Alcoholism -- Treatment -- Periodicals; Substance-abuse -- Treatment -- Periodicals; Alcoholism -- Periodicals; Substance-Related Disorders -- Periodicals; 616.86
• DOI: 10.1080/00952990.2017.1376677
• Languages: English
• ISSNs: 0095-2990

Abstract

ABSTRACT: Background : The Cannabis Use Disorders Identification Test-Revised (CUDIT-R) is an 8-item measure used to screen for cannabis use disorders (CUD). Despite widespread use of the tool, assessments of the CUDIT-R's validity in subpopulations are limited. Objectives : The current study tested the structural validity and internal consistency of one of the most widely used screening measures for CUD (i.e., CUDIT-R) among a sample of military veterans who use cannabis for medicinal purposes. Methods : The present study used confirmatory factor analysis (CFA) to test the internal consistency and validity of the single-factor structure of the original screener among a sample of veterans who use cannabis for medicinal purposes ( n = 90 [90% male]; Mage = 55.31, SD = 15.37). Measures included demographics and the CUDIT-R, obtained from the baseline assessment of an ongoing longitudinal study. Results : The CFA revealed that the single-factor model previously validated in recreational using samples only accounted for 38.34% of total variance in responses on the CUDIT-R ( χ 2 = 66.09, df = 28, p < 0.05; RMSEA = 0.06) and demonstrated acceptable but modest internal consistency (Cronbach's α = 0.73). Conclusion : More psychometric work is needed to determine the reliability and validity of using the CUDIT-R to screen for CUD among military veterans who use medicinal cannabis and other subpopulations of cannabis users.